study_ids
sequence | corpus
string |
|---|---|
[
"NCT02195479",
"NCT02252172"
] |
Transplant Ineligible
|
[
"NCT02195479",
"NCT00114101",
"NCT02541383",
"NCT02541383",
"NCT01660633",
"NCT00551928",
"NCT00551928",
"NCT02874742",
"NCT00430365",
"NCT02252172",
"NCT01554852",
"NCT01554852"
] |
Newly Diagnosed Multiple Myeloma (NDMM)
|
[
"NCT02195479",
"NCT03180736",
"NCT03158688",
"NCT02541383",
"NCT02541383",
"NCT02136134",
"NCT03277105",
"NCT02874742",
"NCT02990338",
"NCT03275285",
"NCT02252172",
"NCT03412565",
"NCT02076009",
"NCT01985126"
] |
Anti-CD38 MAb
|
[
"NCT02195479",
"NCT00103662",
"NCT03180736",
"NCT02412878",
"NCT01080391",
"NCT03110562",
"NCT00114101",
"NCT03158688",
"NCT02541383",
"NCT02541383",
"NCT02136134",
"NCT03277105",
"NCT04162210",
"NCT01239797",
"NCT01568866",
"NCT00551928",
"NCT00551928",
"NCT02990338",
"NCT00430365",
"NCT03275285",
"NCT04181827",
"NCT03651128",
"NCT02252172",
"NCT05083169",
"NCT01554852",
"NCT01554852",
"NCT01311687",
"NCT03151811",
"NCT01734928",
"NCT01023308",
"NCT02076009",
"NCT01712789",
"NCT01564537"
] |
Phase 3
|
[
"NCT02195479"
] |
Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
|
[
"NCT02195479"
] |
Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
ALCYONE
|
[
"NCT02195479",
"NCT02252172"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM)
|
[
"NCT02195479",
"NCT02252172"
] |
Transplant Ineligible, Anti-CD38 MAb
|
[
"NCT02195479",
"NCT02252172"
] |
Transplant Ineligible, Phase 3
|
[
"NCT02195479"
] |
Transplant Ineligible, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, ALCYONE
|
[
"NCT02195479",
"NCT02541383",
"NCT02541383",
"NCT02874742",
"NCT02252172"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb
|
[
"NCT02195479",
"NCT00114101",
"NCT02541383",
"NCT02541383",
"NCT00551928",
"NCT00551928",
"NCT00430365",
"NCT02252172",
"NCT01554852",
"NCT01554852"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Phase 3
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), ALCYONE
|
[
"NCT02195479",
"NCT03180736",
"NCT03158688",
"NCT02541383",
"NCT02541383",
"NCT02136134",
"NCT03277105",
"NCT02990338",
"NCT03275285",
"NCT02252172",
"NCT02076009"
] |
Anti-CD38 MAb, Phase 3
|
[
"NCT02195479"
] |
Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
|
[
"NCT02195479"
] |
Anti-CD38 MAb, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Anti-CD38 MAb, ALCYONE
|
[
"NCT02195479"
] |
Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
|
[
"NCT02195479"
] |
Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Phase 3, ALCYONE
|
[
"NCT02195479"
] |
Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
|
[
"NCT02195479"
] |
Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
|
[
"NCT02195479",
"NCT02252172"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb
|
[
"NCT02195479",
"NCT02252172"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Phase 3
|
[
"NCT02195479"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), ALCYONE
|
[
"NCT02195479",
"NCT02252172"
] |
Transplant Ineligible, Anti-CD38 MAb, Phase 3
|
[
"NCT02195479"
] |
Transplant Ineligible, Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Anti-CD38 MAb, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Anti-CD38 MAb, ALCYONE
|
[
"NCT02195479"
] |
Transplant Ineligible, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Phase 3, ALCYONE
|
[
"NCT02195479"
] |
Transplant Ineligible, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
|
[
"NCT02195479"
] |
Transplant Ineligible, Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
|
[
"NCT02195479",
"NCT02541383",
"NCT02541383",
"NCT02252172"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Phase 3
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, ALCYONE
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, ALCYONE
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
|
[
"NCT02195479"
] |
Anti-CD38 MAb, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
|
[
"NCT02195479"
] |
Anti-CD38 MAb, Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Anti-CD38 MAb, Phase 3, ALCYONE
|
[
"NCT02195479"
] |
Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
|
[
"NCT02195479"
] |
Anti-CD38 MAb, Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
|
[
"NCT02195479"
] |
Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
|
[
"NCT02195479"
] |
Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
|
[
"NCT02195479"
] |
Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
|
[
"NCT02195479",
"NCT02252172"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Phase 3
|
[
"NCT02195479"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, ALCYONE
|
[
"NCT02195479"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, ALCYONE
|
[
"NCT02195479"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
|
[
"NCT02195479"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
|
[
"NCT02195479"
] |
Transplant Ineligible, Anti-CD38 MAb, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Anti-CD38 MAb, Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Anti-CD38 MAb, Phase 3, ALCYONE
|
[
"NCT02195479"
] |
Transplant Ineligible, Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
|
[
"NCT02195479"
] |
Transplant Ineligible, Anti-CD38 MAb, Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
|
[
"NCT02195479"
] |
Transplant Ineligible, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
|
[
"NCT02195479"
] |
Transplant Ineligible, Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
|
[
"NCT02195479"
] |
Transplant Ineligible, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Phase 3, ALCYONE
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
|
[
"NCT02195479"
] |
Newly Diagnosed Multiple Myeloma (NDMM), Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
|
[
"NCT02195479"
] |
Anti-CD38 MAb, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
[
"NCT02195479"
] |
Anti-CD38 MAb, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), ALCYONE
|
[
"NCT02195479"
] |
Anti-CD38 MAb, Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
|
[
"NCT02195479"
] |
Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
|
[
"NCT02195479"
] |
Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP), ALCYONE
|
[
"NCT02195479"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Phase 3, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP)
|
[
"NCT02195479"
] |
Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM), Anti-CD38 MAb, Phase 3, Velcade (Bortezomib) +Melphalan+Prednisone (VMP)
|
End of preview. Expand
in Data Studio
- Downloads last month
- 1